Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

442.33 +5.84 (+1.34%)
Official Closing Price Updated: 7:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
42 43 Next >
Why Novo Nordisk Stock Is Marching Higher Today
Wall Street doesn't seem overly concerned about emerging competition for the company's weight-loss medication. 
Via The Motley Fool
Why Did Eli Lilly Stock Jump 15% in April?
Investors are excited about several candidates in the drug company's pipeline. 
Via The Motley Fool
WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns
The World Health Organization ended the global emergency 
Via Benzinga
Where Will Eli Lilly Be in 3 Years?
The pharmaceutical giant is likely to grow quickly as it is entering a new age of contested markets. 
Via The Motley Fool
3 Things About Eli Lilly That Smart Investors Know
There are quite a few details to keep track of with this company, and they all matter. 
Via The Motley Fool
2 Top Healthcare Stocks Defying the Bear Market
These pharmaceutical companies are expected to see a big rise in revenue, thanks to new therapies. 
Via The Motley Fool
This Is What Whales Are Betting On Eli Lilly
 
Via Benzinga
Why Novo Nordisk Stock Is Slumping Today
A supply shortage for its popular weight-loss drug isn't sitting well with shareholders today. 
Via The Motley Fool
Should Investors Buy This Hot Growth Stock?
This pharmaceutical giant has proved to be a tremendous wealth creator for its shareholders in recent years. 
Via The Motley Fool
2 Best Biotech Stocks to Buy Right Now
Buying pharmaceutical companies with all-around drug portfolios and pipelines is the key to success as an investor. 
Via The Motley Fool
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
The major indexes retreated for most of the week on banking fears, 
Via Investor's Business Daily
Should You Buy Eli Lilly Stock Now?
An important clinical trial with Eli Lilly's Alzheimer's disease candidate just produced successful results. 
Via The Motley Fool
Why Eli Lilly Stock Is Bolting Higher Today
Lilly's Alzheimer's disease candidate might be a best-in-class option for patients. 
Via The Motley Fool
Which Is the Better Passive Income Stock, Eli Lilly or Bristol Myers Squibb?
One offers more income today, and the other aims to offer more in the future. 
Via The Motley Fool
Which Healthcare Stock Is a Compelling Pick for the Long Haul?
Healthcare stocks are especially resilient in times of uncertainty. Let's take a look at three compelling picks. 
Via InvestorPlace
Analysts Say Eli Lilly's Donanemab In Alzheimer's Is Encouraging, Outline Potential Implications For Biogen
Wednesday, Eli Lilly And Co (NYSE: LLY) announced positive results of the TRAILBLAZER-ALZ 2 Phase 3 study of  
Via Benzinga
Mastercard To Rally Around 27%? Here Are 10 Other Analyst Forecasts For Thursday
Needham cut the price target for Datadog, Inc. (NASDAQ: DDOG) from $105 to $90. Needham analyst Mike Cikos maintained a Buy rating. Datadog shares jumped 15.1% to trade at $75.76 on Thursday. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Here's the Best Reason to Buy Eli Lilly Stock Right Now
It has been an important factor behind the drugmaker's market-shattering returns over the past 12 months. 
Via The Motley Fool
7 A-Rated Stocks to Buy for May 2023
This is no time to "sell in May and go away." You'll never get the power of compounding interest that way. Find some stocks to buy instead. 
Via InvestorPlace
These Have Been 3 of the Best-Performing Healthcare Stocks Since 2020
These stocks are all up more than 150% since the start of 2020. 
Via The Motley Fool
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
If you like dividends, these are exactly the kinds of stocks you'll want to own in a market correction. 
Via The Motley Fool
Another Sucess In Alzheimer’s Disease
Eli Lily reported a successful phase III trial of donanemab in Alzheimer’s Disease. How does it differentiate from lecanemab and what does it mean for beta-amyloid treatments? 
Via Talk Markets
Why Is ImmunoGen (IMGN) Stock Up 125% Today?
ImmunoGen (IMGN) stock is rising higher on Wednesday after the company released results from a Phase 3 trial for treating ovarian cancer. 
Via InvestorPlace
LLY Stock Alert: Eli Lilly Announces Positive Alzheimer’s Drug Data
Eli Lilly (LLY) stock is getting a boost on Wednesday after the company announced results from an Alzheimer's clinical trial. 
Via InvestorPlace
Eli Lilly Surges After Alzheimer's Treatment Succeeds; Biogen Also Rises
Eli Lilly is focusing on proteins associated with Alzheimer's disease. 
Via Investor's Business Daily
Good News for Patients Is Lifting These 2 Biopharma Stocks
One stock has nearly doubled Wednesday morning. 
Via The Motley Fool
Why Eli Lilly Shares Are Shooting Higher Today
Eli Lilly And Co (NYSE: LLY) shares are trading higher in the premarket session Wednesday after it announced positive results of the TRAILBLAZER-ALZ 2 Phase 3 study of  
Via Benzinga
Eli Lilly, Livent, Super Micro Computer And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
3 Stocks Quietly Hitting All-Time Highs (and Can Continue Higher)
Despite a tough 2022 and a tricky start to 2023, there are still all-time high stocks to buy even as the markets search for direction. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
42 43 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.